+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astex Pharmaceuticals - logo

Astex Pharmaceuticals is a member of one of Japan's leading pharmaceutical companies, the Otsuka group. It focuses on developing small-molecule therapeutics with a focus on oncology and hematology. Its fragment-based drug discovery platform, Pyramid, has been successfully applied to therapeutic targets addressing a variety of disease areas. The company was formerly known as SuperGen Inc. and changed its name in September 2011. Astex was founded in 1991 and is headquartered in Dublin, California.

Neurofibrosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibrosarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2025

  • Report
  • October 2025
  • 500 Pages
  • Global
From
Gastrointestinal Stromal Tumor Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Gastrointestinal Stromal Tumor Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 101 Pages
  • Global
From
Mantle Cell Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Mantle Cell Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • October 2024
  • 105 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
Relapsed Acute Myeloid Leukemia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Relapsed Acute Myeloid Leukemia Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • July 2024
  • 97 Pages
  • Global
From
Chronic Lymphocytic Leukemia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Chronic Lymphocytic Leukemia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2024
  • 101 Pages
  • Global
From
Myelodysplastic Syndromes Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Myelodysplastic Syndromes Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 90 Pages
  • Global
From
Quantum Computing in Drug Discovery Services Market: Distribution by Drug Discovery Service Offered, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Quantum Computing in Drug Discovery Services Market: Distribution by Drug Discovery Service Offered, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • February 2023
  • 178 Pages
  • Global
From
Fragment-based Drug Discovery - Global Strategic Business Report - Product Thumbnail Image

Fragment-based Drug Discovery - Global Strategic Business Report

  • Report
  • November 2025
  • 193 Pages
  • Global
From
Drug Discovery Market - Global Forecast 2025-2032 - Product Thumbnail Image

Drug Discovery Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 185 Pages
  • Global
From
Small Molecule Drug Discovery Market Report 2025 - Product Thumbnail Image

Small Molecule Drug Discovery Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fragment-Based Drug Discovery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Fragment-Based Drug Discovery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • July 2023
  • 117 Pages
  • Global
From
Outsourcing in Drug Discovery, 9th Edition - Product Thumbnail Image

Outsourcing in Drug Discovery, 9th Edition

  • Report
  • June 2020
  • 294 Pages
  • Global
From
Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chondrosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 116 Pages
  • Global
From
Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 119 Pages
  • Global
From
Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2023
  • 29 Pages
From
Loading Indicator